Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.9050
+0.0350 (1.87%)
NASDAQ· Last Trade: Jun 24th, 1:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors